Back

A paradoxical relationship between mitochondrial calcium regulation and retinal ganglion cell degeneration after axon damage

McCracken, S.; Zhao, M.; Squirrell, K. J.; Zhao, C.; Behboudi Tanourlouee, S.; Aum, M.; Williams, P. R.

2026-05-15 neuroscience
10.64898/2026.05.13.724793 bioRxiv
Show abstract

Retinal ganglion cells (RGCs) degenerate in optic neuropathies like glaucoma and traumatic optic nerve injury leading to irreversible vision loss. Higher levels of homeostatic Ca2+ and canonical Ca2+ regulated signaling promote RGC survival in animal models of glaucoma and optic nerve injury. Mitochondrial dysfunction is also a hallmark of degenerating neurons, including RGCs. Here, we investigate the intersection of mitochondrial function, Ca2+ homeostasis, and cellular resilience by performing an optic nerve crush model of RGC degeneration while monitoring and manipulating mitochondrial Ca2+ levels (mito-Ca2+). We find that mito-Ca2+ is predicative of RGC survival in that surviving RGCs are enriched for higher homeostatic mito-Ca2+ levels. Mitochondrial dysfunction was observed where mito-Ca2+ was reduced in RGCs after injury, regardless of survival. We then examined the importance of higher mito-Ca2+ in surviving RGCs by altering mito-Ca2+ levels and Ca2+ transit using pharmacological and AAV-mediated approaches. Paradoxically, treatment to decrease mito-Ca2+ increased survival to ONC. We then manipulated mito-Ca2+ permeability by altering the expression levels of the mitochondrial calcium uniporter (MCU) pore forming subunit that allows Ca2+ to enter mitochondria from the cytoplasm. Overexpressing MCU reduced RGC survival to injury, while shRNA knockdown of MCU increased RGC survival. These results reveal a complex relationship between mito-Ca2+ and RGC degeneration and suggest that well-surviving RGCs may be under chronic mitochondrial stress due to higher homeostatic mito-Ca2+ levels.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
eLife
5422 papers in training set
Top 2%
17.2%
2
The Journal of Neuroscience
928 papers in training set
Top 1%
9.9%
3
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 12%
6.3%
4
Cell Reports
1338 papers in training set
Top 8%
6.3%
5
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.1%
4.8%
6
Current Biology
596 papers in training set
Top 4%
4.5%
7
Experimental Neurology
57 papers in training set
Top 0.2%
3.9%
50% of probability mass above
8
iScience
1063 papers in training set
Top 6%
3.0%
9
Developmental Cell
168 papers in training set
Top 7%
2.6%
10
Neurobiology of Disease
134 papers in training set
Top 2%
2.4%
11
JCI Insight
241 papers in training set
Top 2%
2.3%
12
Neuron
282 papers in training set
Top 5%
2.3%
13
Scientific Reports
3102 papers in training set
Top 51%
2.0%
14
Cell Death & Disease
126 papers in training set
Top 0.8%
1.9%
15
eneuro
389 papers in training set
Top 5%
1.8%
16
Aging Cell
144 papers in training set
Top 2%
1.7%
17
The Journal of Physiology
134 papers in training set
Top 0.8%
1.6%
18
Brain Communications
147 papers in training set
Top 2%
1.3%
19
Brain
154 papers in training set
Top 3%
1.3%
20
Nature Communications
4913 papers in training set
Top 56%
1.3%
21
PLOS Genetics
756 papers in training set
Top 11%
1.2%
22
Science Advances
1098 papers in training set
Top 24%
1.2%
23
Glia
74 papers in training set
Top 0.4%
0.9%
24
EMBO reports
136 papers in training set
Top 6%
0.8%
25
Frontiers in Neurology
91 papers in training set
Top 5%
0.8%
26
PLOS Biology
408 papers in training set
Top 20%
0.7%
27
Journal of Biological Chemistry
641 papers in training set
Top 5%
0.7%
28
Function
15 papers in training set
Top 0.7%
0.6%
29
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.8%
0.6%